Knowing when to doubt it is as important as knowing how to read it
Before a surgeon reopens an infected joint, she must know her enemy — and for decades, a pre-operative needle culture has been trusted to name it. A large European study now reveals that in more than one-third of cases, that identification is wrong, incomplete, or misleading by the time the operating room tells its own truth. The gap between what we believe before we cut and what we find when we do is not merely technical; it is a reminder that medical certainty is always provisional, and that the tools we trust most deserve the scrutiny we reserve for those we doubt.
- Over one in three periprosthetic infection cases show a mismatch between pre-surgical culture results and what surgeons actually find inside the joint — a discordance rate that can send treatment down the wrong path from the start.
- The stakes are not abstract: incorrect microbial identification can mean the wrong antibiotics, the wrong surgical strategy, and an infection that persists or worsens despite intervention.
- The variability is not random — the hospital performing the procedure is the single strongest predictor of discordance, with an odds ratio of 4.22, exposing deep inconsistencies in how samples are collected, handled, and processed across institutions.
- Hip replacements and patients with fistulas face the highest risk of misleading results, flagging specific populations who need immediate broad-spectrum antibiotic coverage rather than targeted therapy based on pre-operative findings alone.
- The study calls for each hospital to track its own discordance rate continuously and treat pre-operative cultures as contextual guidance — valuable, but never the final word until intra-operative confirmation arrives.
Before a surgeon reopens an infected joint replacement, she needs to know what bacteria she is fighting. A needle aspiration of the joint before surgery has long been the standard way to find out — the culture result shapes the entire treatment plan, from antibiotic choice to whether surgery proceeds in one stage or two. The assumption has been that this pre-operative sample reliably reflects what is actually inside the joint. A major European study now challenges that assumption.
The research, coordinated by the ESCMID Study Group of Implant Associated Infections, drew on data from 16 hospitals across 10 European countries between 2020 and 2024. Among 647 patients undergoing revision surgery for infected hip or knee replacements, the pre-operative synovial culture and the intra-operative findings disagreed in 36 percent of cases. The microbe identified before surgery was absent, different, or incomplete compared to what the operating room revealed.
The discordance was not random. The most powerful predictor was the hospital itself — with an odds ratio of 4.22, institutional variation dwarfed other factors, pointing to inconsistencies in how samples are aspirated, transported, and processed in the microbiology lab. The presence of a fistula was the second major risk factor, as chronic skin openings invite contamination and polymicrobial complexity. Hip replacements posed greater risk than knee procedures, largely because the joint is harder to puncture cleanly, increasing the likelihood of inadequate or contaminated samples.
One finding upended a common assumption: bacteria often dismissed as contaminants — coagulase-negative staphylococci, Corynebacterium, Cutibacterium — did not drive higher discordance rates. When isolated rigorously and paired with clinical signs of infection, these organisms frequently proved to be genuine pathogens. The problem was not the bacteria but the interpretation applied to them.
The practical guidance is clear. Pre-operative cultures should be treated as informative clues, not definitive verdicts. High-risk patients — those with fistulas or undergoing hip revision — should receive broad-spectrum antibiotics immediately after surgery, held until intra-operative results confirm the true pathogen. Hospitals should monitor their own discordance rates and refine collection protocols accordingly. The synovial culture remains a useful tool, but its limits are now better mapped — and knowing when to doubt a result may matter as much as knowing how to read one.
Before a surgeon reopens an infected hip or knee replacement, she needs to know what bacteria caused the problem. A needle puncture into the joint before surgery can tell her that. The culture result guides everything that follows—whether to operate in one stage or two, which antibiotics to use, how aggressive to be. It seems straightforward. It is not.
A European research consortium set out to measure how often the bacteria found in that pre-operative needle sample matched what surgeons actually discovered when they opened the joint during revision surgery. The answer unsettled them. In more than one case out of three—36 percent—the cultures did not agree. The microbe identified before surgery was either absent, different, or incomplete compared to what the operating room revealed. This is not a minor discrepancy. It is a decision-making problem.
The study, coordinated by the ESCMID Study Group of Implant Associated Infections, pulled together data from 16 hospitals across 10 European countries between January 2020 and January 2024. The researchers examined 647 patients who underwent revision surgery for infected hip or knee replacements, all of whom had positive pre-operative synovial cultures and at least three intra-operative cultures taken during surgery. The question was simple: how often did the two methods tell the same story?
They did not. The 36 percent discordance rate confirmed what smaller studies had hinted at for years—that pre-operative needle cultures are unreliable guides more often than most surgeons assume. The variability was not random. Three independent factors predicted when disagreement was most likely. First and most striking was the hospital itself. The odds ratio was 4.22, meaning that discordance rates varied wildly between centers. This pointed to procedural differences: how samples were aspirated, how they were handled in sterile conditions, how they were transported, and how the microbiology lab processed them. No two hospitals did it quite the same way, and those differences mattered.
The second risk factor was the presence of a fistula—a chronic opening that connected the infected joint to the skin. When that pathway exists, contamination from the outside world can muddy the sample, or multiple bacteria can colonize the wound. The culture becomes less trustworthy. The third factor was hip replacement itself. The hip joint is harder to puncture cleanly than the knee, especially in obese patients. Inadequate or contaminated samples were more common, raising the chance of a misleading result.
One finding surprised the researchers. Bacteria traditionally dismissed as contaminants—coagulase-negative staphylococci, Corynebacterium, Cutibacterium—did not correlate with higher discordance rates. The assumption had been that these organisms would produce false positives and confuse the picture. Instead, when isolated with rigorous criteria and paired with clinical and laboratory signs of actual infection, these bacteria often turned out to be the real culprits. The problem was not the bacteria themselves but the interpretation.
The practical message is sobering but clear. A positive pre-operative synovial culture should not be treated as gospel. It is a clue, not a verdict. Patients with fistulas or those undergoing hip revision should receive broad-spectrum antibiotics immediately after surgery, held until the definitive intra-operative culture results come back days later. Each hospital should know its own discordance rate and track it continuously, adjusting collection and processing protocols when the numbers drift. The synovial culture remains a valuable tool. But it is imperfect, and knowing when to doubt it is as important as knowing how to read it.
Notable Quotes
The synovial culture is a valuable tool, but it is imperfect. Knowing when to distrust it is as important as knowing how to interpret it.— Study findings via European research consortium
The Hearth Conversation Another angle on the story
Why does it matter so much if the pre-operative culture doesn't match what they find during surgery?
Because the surgeon is making decisions in the dark. She's choosing antibiotics, deciding whether to do one operation or two, planning how much tissue to remove. If the culture is wrong, all those decisions are built on false information.
But they get the real answer once they open the joint, don't they?
Yes, but by then it's too late to change the pre-operative antibiotic choice. The patient gets broad-spectrum coverage while waiting for those results, which is safe but not ideal. And if the surgeon planned her approach based on the wrong organism, she might not have removed enough infected material.
The study found that hip replacements had higher discordance than knees. Why?
The hip is deeper, harder to reach with a needle. In heavier patients especially, you can't always get a clean sample. You might hit scar tissue, get contamination, or miss the joint space entirely.
What about those bacteria that everyone assumes are just contamination?
That was the surprise. When you apply strict criteria—multiple positive cultures, clinical signs of infection—those supposedly harmless bacteria often turn out to be the real problem. We've been too quick to dismiss them.
So what should a surgeon do with a positive pre-operative culture now?
Treat it as context, not certainty. Use it to inform your thinking, but don't let it narrow your antibiotic coverage too early. And if you're in a hospital with a high discordance rate, be even more cautious. Know your own numbers.